Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 3:41 PM ET

Date/Time Source News Release
09/25/2024 08:00 AM EDT PR Newswire Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology
09/19/2024 07:00 AM EDT PR Newswire Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases
04/04/2024 05:06 PM EDT PR Newswire Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023
03/15/2024 09:00 AM EDT PR Newswire Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis
11/20/2023 04:32 PM EST PR Newswire Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
09/26/2023 08:30 AM EDT PR Newswire Galmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal Fibrosis
09/22/2023 04:05 PM EDT PR Newswire Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
07/14/2023 09:30 AM EDT PR Newswire Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering
07/10/2023 08:00 AM EDT PR Newswire Galmed to employ OnKai's disruptive Artificial Intelligence (AI) in its Planned Phase 2a Clinical Trial in PSC
06/01/2023 08:00 AM EDT PR Newswire Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Developments
Page

Additional News

As of January 3, 2025 • 3:41 PM ET

Date/Time Source News Release
11/23/2024 04:40 AM EST US Earnings Reports Expected earnings - Galmed Pharmaceuticals Ltd.
11/14/2024 05:25 PM EST SeekingAlpha Galmed files for $200M mixed securities shelf
10/21/2024 04:42 PM EDT SeekingAlpha Galmed Pharmaceuticals files for offering of common stock
10/01/2024 05:39 AM EDT US Earnings Reports Expected earnings - Galmed Pharmaceuticals Ltd.
09/26/2024 04:16 PM EDT Stock Traders Daily (GLMD) Long Term Investment Analysis
09/20/2024 09:00 AM EDT Financial News Media How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
09/19/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Thu, Sep 19, 2024 as of 10.00 am ET
09/18/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Wed, Sep 18, 2024 as of 4:00 pm ET
09/18/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Wed, Sep 18, 2024 as of 10.00 am ET
09/17/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Tue, Sep 17, 2024 as of 4:00 pm ET
Page